According to these findings, tumour therapies aimed against ATP7A/B have achieved progress in specific tumours (Aubert et al., 2020; Petruzzelli and Polishchuk, 2019; Arnesano et al., 2011; Lukanović et al., 2020). This evidence concerns the gene ATP7A and neoplasm.